Search results
- 1.0472010 - ÚMG 2017 RIV US eng J - Journal Article
Otáhal, Pavel - Průková, D. - Král, Vlastimil - Fábry, Milan - Vockova, P. - Lateckova, L. - Trněný, M. - Klener, P.
Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells.
Oncoimmunology. Roč. 5, č. 4 (2016), č. článku e1115940. ISSN 2162-402X. E-ISSN 2162-402X
R&D Projects: GA MZd(CZ) NT13201
Institutional support: RVO:68378050
Keywords : Chimeric antigenic receptor * lenalidomide * lymphoma * tumor immunotherapy * T cells
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 7.719, year: 2016
Permanent Link: http://hdl.handle.net/11104/0269367 - 2.0394700 - ÚMG 2013 RIV US eng J - Journal Article
Beranová, Lenka - Pombinho, António R. - Špegárová, Jarmila - Koc, Michal - Klánová, M. - Molinsky, J. - Klener, P. - Bartůněk, Petr - Anděra, Ladislav
The plant alkaloid and anti-leukemia drug homoharringtonine sensitizes resistant human colorectal carcinoma cells to TRAIL-induced apoptosis via multiple mechanisms.
Apoptosis. Roč. 18, č. 6 (2013), s. 739-750. ISSN 1360-8185. E-ISSN 1573-675X
R&D Projects: GA ČR GAP301/10/1971; GA MŠMT LH12202; GA MŠMT(CZ) LC06077; GA MZd(CZ) NT13201; GA MŠMT LM2011022
Grant - others:UK(CZ) P24/LF1/3; GA UK(CZ) 259211/110709; UK(CZ) UNCE 204021
Institutional support: RVO:68378050
Keywords : harringtonine * apoptosis * death receptor * cFLIP * Mcl-1
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 3.614, year: 2013
Permanent Link: http://hdl.handle.net/11104/0222900File Download Size Commentary Version Access 0394700.pdf 3 893.7 KB Publisher’s postprint require 0394700.pdf 3 893.4 KB Publisher’s postprint require